Testing effectiveness (Phase 2)Study completedNCT02165202
What this trial is testing
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Who this might be right for
Human Immunodeficiency Virus (HIV)
PATH 136